Last updated 2026-07-20
- Acquired by Advanced Medical Solutions Group (AMS) for $25M, Jan 2019
- Raised Undisclosed Round led by Teuza, Oct 2016
Total raised
—
Last: Undisclosed Round 2016-11
Stage
Acquired
Founded
2007
Headcount
12
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Sealantis develops innovative products based on a proprietary platform of alga-mimetic tissue adhesives for a variety of applications and clinical needs in surgical adhesion, leakage control, adhesion-prevention, and drug delivery. The technology mimics the underwater adherence mechanism of algae, providing superior ability to stick to tissues and grafts even in wet environments. The adhesives are bioresorbable and protein-free, reducing risks of infection or allergic reactions.
Funding history · 1 round · — total
2016-10
Undisclosed Round
Undisclosed
★ Teuza
Q&A
- What is Sealantis' primary focus?
- Sealantis, also known as AMS Israel, develops protein-free tissue adhesives based on proprietary alga-mimetic formulations for various surgical applications, mimicking the underwater adherence mechanism of algae.
- When was Sealantis acquired and by whom?
- Sealantis was acquired by Advanced Medical Solutions Group in January 2019.
- What is Seal-V?
- Seal-V is Sealantis' first product, a surgical sealant designed for use in various vascular procedures to control bleeding.
- What is Seal-G and when did it receive CE mark?
- Seal-G is a gastrointestinal bioresorbable sealant designed to secure gastrointestinal anastomoses. It received the CE mark in 2018.
- What other products does Sealantis offer?
- Sealantis also offers the Orthopedic Adhesion Barrier, an extra-articular bioresorbable gel designed to prevent tissue adhesions and speed recovery of injured joints.
- Who was a lead investor in Sealantis' funding round in November 2016?
- Teuza was a lead investor in Sealantis' funding round in November 2016.
- Where was Sealantis' technology developed?
- Sealantis' technology was developed under the umbrella of the Alfred Mann Institute at the Technion.
Team · 1
Prof. Havazelet Bianco-Peled
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesAdhesive
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
surgerymedical-technologiesoperating-roomsvascularsurgeonsdrug-deliveryhospitalsbiodegradableadhesivesorthopedicsgastroenterologybiomaterials
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sealantis.com/ |
|---|
Identifiers & details
| Founded | 2007 |
|---|---|
| Employees (exact) | 12 |
| Status reason | Acquired (Inactive) by Advanced Medical Solutions Group on Jan 2019 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Advanced Medical Solutions Group (AMS) 2019-01 $25.0M
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | sealantis.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514346295 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2009-11-08 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | שד שיקגו 1 חיפה |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-27 | דו~ח שנתי |